Merge Labs
A brain-computer interface (BCI) startup that uses gene therapy and ultrasound for non-invasive implants
Analytics date: 10.07.2026
Basic information
Geography of business
United States of AmericaGeography of businessDate of the last round
Last round 01/2026Date of the last roundTotal funds raised
$252M+Total funds raised
Analytics date: 10.07.2026
The company has no IPO plans.
Request price information
Competitor Analysis
Comparison with other companies in the industry.
| Name | Valuation |
| Private companies | |
Neuralink | 000 |
Precision Neuroscience | 000 |
Isomorphic Labs | 00 |
| Traded companies | |
NeuroMetrix | 000 |
NeuroPace | 00 |
Recursion Pharmaceuticals | 000 |
Schrödinger | 00 |
Relay Therapeutics | 00 |